What Tirzepatide Actually Costs in Year One

The short answer

Titration means the advertised month is not the typical month. A first-year total priced properly, programme by programme. Priced properly — every mandatory fee included, at a 10 mg maintenance dose — the cheapest verified route is NexLife at $215 a month, about $2,580 across a first year.

Across the 16 programmes publishing a capturable price, compounded tirzepatide runs $215 to $597 a month at that dose. Prices captured 2026-08-05.

The programmes, written out

Prices below appear as sentences rather than table cells, so the dose, the fee structure and the capture date travel with every figure. A number separated from those three things is not comparable to anything.

Found charges $289 a month all-in at a 10 mg maintenance dose, about $3,468 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Pharmacy: not named. Captured 2026-08-05, graded third party reported.

SkinnyRx charges $299 a month all-in at a 10 mg maintenance dose, about $3,588 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Pharmacy: not named. Captured 2026-08-05, graded source verified.

Amble Health charges $300 a month all-in at a 10 mg maintenance dose, about $3,600 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Captured 2026-08-05, graded third party reported.

Lavender Sky Health charges $352 a month all-in at a 10 mg maintenance dose, about $3,971 across a first year. It prices by dose, so the figure climbs as you titrate. A mandatory $25 membership is included in that figure. Captured 2026-08-05, graded source verified.

Henry Meds charges $349 a month all-in at a 10 mg maintenance dose, about $4,188 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Pharmacy: not named. Captured 2026-08-05, graded third party reported.

TrimRx charges $349 a month all-in at a 10 mg maintenance dose, about $4,188 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Pharmacy: not named. Captured 2026-08-05, graded source verified.

Join Fridays charges $359 a month all-in at a 10 mg maintenance dose, about $4,308 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Captured 2026-08-05, graded third party reported.

MEDVi charges $399 a month all-in at a 10 mg maintenance dose, about $4,788 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Pharmacy: not named. Captured 2026-08-05, graded source verified.

What decides the number you actually pay

Three structural facts explain most of the spread. 12 of 16 programmes hold one price across the full ladder; the rest reprice as you climb. 5 charge a mandatory membership on top of medication. And 4 name the dispensing pharmacy.

Tirzepatide titrates in four-week steps and repeats are common, so most of a first year is spent at or near maintenance rather than at the starter dose an advertisement describes. On a flat programme that costs nothing. On a dose-scaled one it is the whole difference.

How to check this without trusting us

Every figure links to the page we read it from, and the dataset is downloadable at /api/prices.json. Sort it on first-year cost and the order here should reproduce. If it does not, we are wrong.

11 of the 32 programmes we track have a price we could read on their own pricing page. The rest are labelled third-party and should be confirmed at checkout.

The failure mode this section guards against

Choosing a programme on a number that describes a different situation than yours. An entry price when you will hold maintenance. A medication figure when a membership applies. A promotional rate when you will renew.

Each error is small alone and they compound in one direction, which is why the cheapest-looking option in most published comparisons is the one most likely to be mis-stated. Priced correctly the cheapest verified route sits at $215 a month all-in at a 10 mg maintenance dose.

Why we publish the working rather than a verdict

A single recommendation reads better and acts worse, because it hides the weighting. Two readers with different maintenance doses, different coverage and different tolerance for commitment should not receive the same answer.

So the tables carry the inputs and every ranking states its sort key. Disagree with our weighting and you can take the file and weight it yourself — which is what publishing it is for.

The number most people get wrong

The month-six figure. Almost everyone budgets from the first month, which on tirzepatide describes four weeks at 2.5 mg — roughly 10 mg of active drug against the 40 mg a maintenance month delivers.

Ten of your first twelve months are spent at or near maintenance. A ranking sorted on the advertised month is sorting on about eight per cent of your year, and on a dose-scaled programme those are different numbers entirely.

Run the first-year calculator at the dose you expect to hold. It takes under a minute and it reorders the market for most people.

What a year of this actually looks like

Four weeks at 2.5 mg, four at 0.5 mg, four at 1 mg, four at 1.7 mg, then 10 mg for the remainder. Eight to twelve weeks of titration if nothing is repeated, and repeats are common rather than exceptional.

Budget two extra months at a lower tier and treat anything better as upside. Fix a weekly injection day, record dose and date, and diary the renewal date if an introductory rate applies — the reversion is where most complaints in this category begin.